COMMUNIQUÉS West-GlobeNewswire
-
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
09/03/2026 -
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
09/03/2026 -
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
09/03/2026 -
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/03/2026 -
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
09/03/2026 -
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results
09/03/2026 -
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
10/03/2026 -
The Right to Religious Exemption to Vaccination Upheld in Court, according to the Journal of American Physicians and Surgeons
09/03/2026 -
Novonesis named a Great Employer to Work For in North Carolina
09/03/2026 -
Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas
09/03/2026 -
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
09/03/2026 -
Direct Meds GLP-1 Program Report 2026: Compounded Semaglutide and Tirzepatide Pricing, Telehealth Access, and Consumer Verification Factors
09/03/2026 -
AEON Biopharma Appoints John Bencich as Chief Financial Officer
09/03/2026 -
COVID mRNA Vaccines May Alter Gene Expression, according to Journal of American Physicians and Surgeons
09/03/2026 -
Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology
09/03/2026 -
Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
09/03/2026 -
Update: Ipsen retire volontairement Tazverik® (tazemetostat) dans le traitement du lymphome folliculaire et du sarcome épithélioïde
09/03/2026 -
MemoTril Consumer Concerns Under Investigation: Critiquing The Memo Tril Claims
09/03/2026 -
The Great Give Back brings community together in support of Royal Columbian Hospital
09/03/2026
Pages